312 related articles for article (PubMed ID: 17135738)
21. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
Guenther LC
Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
[TBL] [Abstract][Full Text] [Related]
22. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
Jemec GB; van de Kerkhof PC; Enevold A; Ganslandt C
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):27-32. PubMed ID: 20456557
[TBL] [Abstract][Full Text] [Related]
23. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
White S; Vender R; Thaçi D; Haverkamp C; Naeyaert JM; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
Am J Clin Dermatol; 2006; 7(3):177-84. PubMed ID: 16734505
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
25. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
McCormack PL
Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
[TBL] [Abstract][Full Text] [Related]
26. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
27. Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study.
Toole JW
Skin Therapy Lett; 2007 May; 12(4):1-3. PubMed ID: 17551662
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
29. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Rigopoulos D; Gregoriou S; Daniel Iii CR; Belyayeva H; Larios G; Verra P; Stamou C; Kontochristopoulos G; Avgerinou G; Katsambas A
Dermatology; 2009; 218(4):338-41. PubMed ID: 19212110
[TBL] [Abstract][Full Text] [Related]
30. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Fenton C; Plosker GL
Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
[TBL] [Abstract][Full Text] [Related]
31. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL
Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
[TBL] [Abstract][Full Text] [Related]
32. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
Anstey AV; Kragballe K
Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
[TBL] [Abstract][Full Text] [Related]
33. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
34. Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial.
Langley RG; Gupta A; Papp K; Wexler D; Østerdal ML; Curčić D
Dermatology; 2011; 222(2):148-56. PubMed ID: 21293107
[TBL] [Abstract][Full Text] [Related]
35. Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
Vakirlis E; Kastanis A; Lazaridou E; Loannides D; Chrysomallis F
Int J Clin Pharmacol Res; 2005; 25(4):165-8. PubMed ID: 16402632
[TBL] [Abstract][Full Text] [Related]
36. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
37. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
Duweb G; Alhaddar J; Elsherif B; Eljehawi N; Makhlouf H
Drugs Exp Clin Res; 2005; 31(5-6):175-9. PubMed ID: 16425973
[TBL] [Abstract][Full Text] [Related]
38. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
[TBL] [Abstract][Full Text] [Related]
39. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
40. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
